Annual and transition report of foreign private issuers pursuant to Section 13 or 15(d)

Commitments (Details)

v3.24.1.1.u2
Commitments (Details) - USD ($)
 12 Months Ended
Dec. 31, 2023
Dec. 31, 2022
Commitments    
payments for activities related to its clinical trial $ 446,000 $ 1,994,232